Effect of PRM-125 on Ambulatory Blood Pressure
JT
Overseen ByJoseph T McDevitt
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: PRM Pharma, LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the purpose of this trial?
This trial tests if a once-daily medication, PRM125, can lower blood pressure throughout the day in adults with high blood pressure.
Eligibility Criteria
Inclusion Criteria
primary hypertension
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Treatment
Participants receive PRM125 once daily for 8 weeks to evaluate changes in ambulatory blood pressure
8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
4 weeks
Treatment Details
Interventions
- PRM-125
Participant Groups
1Treatment groups
Experimental Treatment
Group I: PRM125Experimental Treatment1 Intervention
PRM125
Find a Clinic Near You
Who Is Running the Clinical Trial?
PRM Pharma, LLC
Lead Sponsor
Trials
1
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.